{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T19:58:26Z","timestamp":1791316706289,"version":"4.3.1"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","lungcancerjournal.info","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Lung Cancer"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.lungcan.2026.109418","type":"journal-article","created":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T15:42:26Z","timestamp":1776440546000},"page":"109418","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Comparative analysis of therapeutic target protein expression in de novo and transformed small cell lung carcinomas using paired biopsy samples"],"prefix":"10.1016","volume":"216","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9684-2920","authenticated-orcid":false,"given":"Saori","family":"Murata","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5225-9319","authenticated-orcid":false,"given":"Jumpei","family":"Kashima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9090-801X","authenticated-orcid":false,"given":"Hidehito","family":"Horinouchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-3621-9332","authenticated-orcid":false,"given":"Satsuki","family":"Kishikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7736-3737","authenticated-orcid":false,"given":"Ken","family":"Masuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1813-4184","authenticated-orcid":false,"given":"Yuki","family":"Shinno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuke","family":"Okuma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsuya","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasushi","family":"Goto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0787-2851","authenticated-orcid":false,"given":"Noboru","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-1927-9675","authenticated-orcid":false,"given":"Shun-ichi","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0646-858X","authenticated-orcid":false,"given":"Yuji","family":"Matsumoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kae","family":"Okuma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasushi","family":"Yatabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.lungcan.2026.109418_b0005","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.omto.2021.02.004","article-title":"Molecular profiles of small cell lung cancer subtypes: therapeutic implications","volume":"20","author":"Schwendenwein","year":"2021","journal-title":"Mol. Ther. Oncolytics"},{"key":"10.1016\/j.lungcan.2026.109418_b0010","doi-asserted-by":"crossref","first-page":"5368","DOI":"10.3390\/cancers15225368","article-title":"Unlocking new horizons in small-cell lung cancer treatment: the onset of antibody-drug conjugates","volume":"15","author":"Belluomini","year":"2023","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.lungcan.2026.109418_b0015","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/s41571-023-00850-2","article-title":"Exploring the next generation of antibody-drug conjugates","volume":"21","author":"Tsuchikama","year":"2024","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.lungcan.2026.109418_b0020","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1056\/NEJMoa2502099","article-title":"Tarlatamab in small-cell lung cancer after platinum-based chemotherapy","volume":"393","author":"Mountzios","year":"2025","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.lungcan.2026.109418_b0025","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.lungcan.2020.07.026","article-title":"International real-world study of DLL3 expression in patients with small cell lung cancer","volume":"147","author":"Rojo","year":"2020","journal-title":"Lung Cancer"},{"key":"10.1016\/j.lungcan.2026.109418_b0030","article-title":"Delta-like protein 3 expression in paired chemonaive and chemorelapsed small cell lung cancer samples","volume":"8","author":"Kuempers","year":"2021","journal-title":"Front. Med. (Lausanne)"},{"key":"10.1016\/j.lungcan.2026.109418_b0035","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1007\/s10637-023-01353-8","article-title":"Immunohistochemical analysis of B7-H3 expression in patients with lung cancer following various anti-cancer treatments","volume":"41","author":"Omori","year":"2023","journal-title":"Invest. New Drugs"},{"key":"10.1016\/j.lungcan.2026.109418_b0040","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1007\/s00432-021-03784-3","article-title":"Trophoblast cell-surface antigen 2 expression in lung cancer patients and the effects of anti-cancer treatments","volume":"148","author":"Omori","year":"2022","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"10.1016\/j.lungcan.2026.109418_b0045","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3002003","article-title":"Genotypic and histological evolution of lung cancers acquiring resistance to EGFR inhibitors","volume":"3","author":"Sequist","year":"2011","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.lungcan.2026.109418_b0050","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1200\/JCO.18.01585","article-title":"EGFR-mutant adenocarcinomas that transform to small-cell lung cancer and other neuroendocrine carcinomas: clinical outcomes","volume":"37","author":"Marcoux","year":"2019","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.lungcan.2026.109418_b0055","doi-asserted-by":"crossref","DOI":"10.1177\/17588359221130503","article-title":"Histologic transformation in lung cancer: when one door shuts, another opens","volume":"14","author":"Sato","year":"2022","journal-title":"Ther. Adv. Med. Oncol."},{"issue":"6","key":"10.1016\/j.lungcan.2026.109418_b0060","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1200\/JCO.21.01626","article-title":"Targeted therapies for lung cancer patients with oncogenic driver molecular alterations","volume":"40","author":"Tan","year":"2022","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.lungcan.2026.109418_b0065","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1111\/his.14872","article-title":"Comparison of ASCL1, NEUROD1, and POU2F3 expression in surgically resected specimens, paired tissue microarrays, and lymph node metastases in small cell lung carcinoma","volume":"82","author":"Handa","year":"2023","journal-title":"Histopathology"},{"key":"10.1016\/j.lungcan.2026.109418_b0070","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1056\/NEJMoa2112431","article-title":"Trastuzumab deruxtecan in HER2-mutant non-small-cell lung cancer","volume":"386","author":"Li","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.lungcan.2026.109418_b0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.114248","article-title":"Targeting the Notch signaling pathway and the Notch ligand, DLL3, in small cell lung cancer","volume":"159","author":"Zhang","year":"2023","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.lungcan.2026.109418_b0080","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.ijrobp.2013.06.2064","article-title":"Radiation-induced Notch signaling in breast cancer stem cells","volume":"87","author":"Lagadec","year":"2013","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.lungcan.2026.109418_b0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejca.2024.115065","article-title":"Small cell transformation in EGFR-mutated non-small cell lung cancer: DLL3 expression and efficacy of immune checkpoint inhibitors or tyrosine kinase inhibitors combined with chemotherapy","volume":"213","author":"Saalfeld","year":"2024","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.lungcan.2026.109418_b0090","article-title":"Brief report: comprehensive clinicogenomic profiling of small cell transformation from EGFR-mutant NSCLC informs potential therapeutic targets","volume":"5","author":"Zhang","year":"2023","journal-title":"JTO Clin. Res. Rep."},{"issue":"10 Suppl 1","key":"10.1016\/j.lungcan.2026.109418_b0095","doi-asserted-by":"crossref","first-page":"S580","DOI":"10.1016\/j.jtho.2025.09.1095","article-title":"P3.18.80 a phase 3 study of sacituzumab govitecan in patients with previously treated extensive stage small cell lung cancer","volume":"20","author":"Dowlati","year":"2025","journal-title":"J. Thorac. Oncol."},{"issue":"4","key":"10.1016\/j.lungcan.2026.109418_b0100","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1200\/JCO-25-02142","article-title":"Ifinatamab deruxtecan in patients with extensive-stage small cell lung cancer: primary analysis of the phase II IDeate-Lung01 trial","volume":"44","author":"Rudin","year":"2026","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.lungcan.2026.109418_b0105","unstructured":"ClinicalTrials.gov. IDeate-Lung02: A Study of Ifinatamab Deruxtecan Versus Treatment of Physician\u2019s Choice in Participants With Relapsed Small Cell Lung Cancer. ClinicalTrials.gov Identifier: NCT06203210. Accessed March 2, 2026. https:\/\/clinicaltrials.gov\/study\/NCT06203210."},{"key":"10.1016\/j.lungcan.2026.109418_b0110","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1200\/JCO-24-01544","article-title":"Datopotamab deruxtecan versus docetaxel for previously treated advanced or metastatic non-small cell lung cancer: the randomized, open-label phase III TROPION-Lung01 study","volume":"43","author":"Ahn","year":"2025","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.lungcan.2026.109418_b0115","doi-asserted-by":"crossref","first-page":"5042","DOI":"10.1158\/1078-0432.CCR-24-1547","article-title":"A phase I first-in-human study of ABBV-011, a seizure-related homolog protein 6-targeting antibody-drug conjugate, in patients with small cell lung cancer","volume":"30","author":"Morgensztern","year":"2024","journal-title":"Clin. Cancer Res."},{"issue":"suppl 16","key":"10.1016\/j.lungcan.2026.109418_b0120","doi-asserted-by":"crossref","first-page":"8502","DOI":"10.1200\/JCO.2023.41.16_suppl.8502","article-title":"First-in-human dose-escalation trial of BI 764532, a delta-like ligand 3 (DLL3)\/CD3 IgG-like T-cell engager in patients with DLL3-positive small-cell lung cancer and neuroendocrine carcinoma","volume":"41","author":"Wermke","year":"2023","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.lungcan.2026.109418_b0125","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.lungcan.2017.11.018","article-title":"Prevalence of delta-like protein 3 expression in patients with small cell lung cancer","volume":"115","author":"Tanaka","year":"2018","journal-title":"Lung Cancer"},{"key":"10.1016\/j.lungcan.2026.109418_b0130","doi-asserted-by":"crossref","first-page":"321","DOI":"10.4103\/IJPM.IJPM_535_20","article-title":"Concordance of HER2 status tested by IHC and FISH in biopsy and surgical resection specimens and comparison with clinicopathological features in gastric carcinoma","volume":"65","author":"Nergiz","year":"2022","journal-title":"Indian J. Pathol. Microbiol."}],"container-title":["Lung Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500226004794?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500226004794?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,28]],"date-time":"2026-06-28T16:22:43Z","timestamp":1782663763000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0169500226004794"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":26,"alternative-id":["S0169500226004794"],"URL":"https:\/\/doi.org\/10.1016\/j.lungcan.2026.109418","relation":{},"ISSN":["0169-5002"],"issn-type":[{"value":"0169-5002","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparative analysis of therapeutic target protein expression in de novo and transformed small cell lung carcinomas using paired biopsy samples","name":"articletitle","label":"Article Title"},{"value":"Lung Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lungcan.2026.109418","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"109418"}}